160 related articles for article (PubMed ID: 11966455)
21. Thiazoles and Thiazolidinones as COX/LOX Inhibitors.
Liaras K; Fesatidou M; Geronikaki A
Molecules; 2018 Mar; 23(3):. PubMed ID: 29562646
[TBL] [Abstract][Full Text] [Related]
22. Cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) selectivity of COX inhibitors.
Sud'ina GF; Pushkareva MA; Shephard P; Klein T
Prostaglandins Leukot Essent Fatty Acids; 2008 Feb; 78(2):99-108. PubMed ID: 18280718
[TBL] [Abstract][Full Text] [Related]
23. Cyclo-oxygenase and lipoxygenase pathways in mast cell dependent-neurogenic inflammation induced by electrical stimulation of the rat saphenous nerve.
Le Filliatre G; Sayah S; Latournerie V; Renaud JF; Finet M; Hanf R
Br J Pharmacol; 2001 Apr; 132(7):1581-9. PubMed ID: 11264253
[TBL] [Abstract][Full Text] [Related]
24. The different inhibitory effects of Huang-Lian-Jie-Du-Tang on cyclooxygenase 2 and 5-lipoxygenase.
Li L; Zeng H; Shan L; Yuan X; Li Y; Liu R; Zhang W
J Ethnopharmacol; 2012 Sep; 143(2):732-9. PubMed ID: 22884869
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities.
Pontiki E; Hadjipavlou-Litina D; Litinas K; Nicolotti O; Carotti A
Eur J Med Chem; 2011 Jan; 46(1):191-200. PubMed ID: 21106277
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of a new class of acyl derivatives of 3-amino-1-phenyl-4,5-dihydro-1H-pyrazol-5-one as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors.
Cusan C; Spalluto G; Prato M; Adams M; Bodensieck A; Bauer R; Tubaro A; Bernardi P; Da Ros T
Farmaco; 2005 Apr; 60(4):327-32. PubMed ID: 15848208
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
Rao PN; Chen QH; Knaus EE
J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of 5-lipoxygenase pathway suppresses the growth of bladder cancer cells.
Hayashi T; Nishiyama K; Shirahama T
Int J Urol; 2006 Aug; 13(8):1086-91. PubMed ID: 16903934
[TBL] [Abstract][Full Text] [Related]
29. 2,3-Diarylxanthones as Potential Inhibitors of Arachidonic Acid Metabolic Pathways.
Santos CMM; Ribeiro D; Silva AMS; Fernandes E
Inflammation; 2017 Jun; 40(3):956-964. PubMed ID: 28285462
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of new phenidone analogues as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors.
Cusan C; Spalluto G; Prato M; Adams M; Bodensieck A; Bauer R; Tubaro A; Bernardi P; Da Ros T
Farmaco; 2005 Jan; 60(1):7-13. PubMed ID: 15652362
[TBL] [Abstract][Full Text] [Related]
31. Benzodioxole-Pyrazole Hybrids as Anti-Inflammatory and Analgesic Agents with COX-1,2/5-LOX Inhibition and Antioxidant Potential.
Abd El Razik HA; Badr MH; Atta AH; Mouneir SM; Abu-Serie MM
Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28418202
[TBL] [Abstract][Full Text] [Related]
32. Lipoxygenase and cyclooxygenase inhibitors reveal a complementary role of arachidonic acid derivatives in pregnant human myometrium.
Corriveau S; Rousseau E; Berthiaume M; Pasquier JC
Am J Obstet Gynecol; 2010 Sep; 203(3):266.e1-7. PubMed ID: 20684944
[TBL] [Abstract][Full Text] [Related]
33. Dual inhibition of 5-lipoxygenase/cyclooxygenase by a reconstituted homeopathic remedy; possible explanation for clinical efficacy and favourable gastrointestinal tolerability.
Jäggi R; Würgler U; Grandjean F; Weiser M
Inflamm Res; 2004 Apr; 53(4):150-7. PubMed ID: 15060721
[TBL] [Abstract][Full Text] [Related]
34. Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
Vo NNQ; Nomura Y; Muranaka T; Fukushima EO
J Nat Prod; 2019 Dec; 82(12):3311-3320. PubMed ID: 31774676
[TBL] [Abstract][Full Text] [Related]
35. Antitumor effects of lipoxygenase inhibitors on murine bladder cancer cell line (MBT-2).
Ikemoto S; Sugimura K; Kuratukuri K; Nakatani T
Anticancer Res; 2004; 24(2B):733-6. PubMed ID: 15161019
[TBL] [Abstract][Full Text] [Related]
36. Anti-inflammatory effects and gastrointestinal safety of NNU-hdpa, a novel dual COX/5-LOX inhibitor.
Xu GL; Liu F; Ao GZ; He SY; Ju M; Zhao Y; Xue T
Eur J Pharmacol; 2009 Jun; 611(1-3):100-6. PubMed ID: 19345206
[TBL] [Abstract][Full Text] [Related]
37. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
[TBL] [Abstract][Full Text] [Related]
38. A dual inhibitor of cyclooxygenase and 5-lipoxygenase protects against kainic acid-induced brain injury.
Minutoli L; Marini H; Rinaldi M; Bitto A; Irrera N; Pizzino G; Pallio G; Calò M; Adamo EB; Trichilo V; Interdonato M; Galfo F; Squadrito F; Altavilla D
Neuromolecular Med; 2015 Jun; 17(2):192-201. PubMed ID: 25893744
[TBL] [Abstract][Full Text] [Related]
39. Licofelone, a novel 5-LOX/COX-inhibitor, attenuates leukocyte rolling and adhesion on endothelium under flow.
Ulbrich H; Soehnlein O; Xie X; Eriksson EE; Lindbom L; Albrecht W; Laufer S; Dannhardt G
Biochem Pharmacol; 2005 Jul; 70(1):30-6. PubMed ID: 15894291
[TBL] [Abstract][Full Text] [Related]
40. Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
Cai H; Huang X; Xu S; Shen H; Zhang P; Huang Y; Jiang J; Sun Y; Jiang B; Wu X; Yao H; Xu J
Eur J Med Chem; 2016 Jan; 108():89-103. PubMed ID: 26638042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
